高危局限性前列腺癌的治疗探讨

参考文献

[1] EAU Guidelines on prostate cancer, 2023.

[2] 中国临床肿瘤学会（CSCO）.前列腺癌诊疗指南（2024 版）.

[3] 中国前列腺癌研究协作组.前列腺癌药物去势治疗随访管理中国专家共识(2024版).中华肿瘤杂志.2024;46(4):285-295.

[4] 中国抗癌协会男性生殖系统肿瘤专业委员会.高危前列腺癌围手术期综合治疗专家共识（2023年版）. 中国癌症杂志. 2023;33(12):1204-1216.

[5] Eastham, J.A. et al.Radiation and Androgen Deprivation Therapy With or Without Docetaxel in the Management of Nonmetastatic Unfavorable-Risk Prostate Cancer: A Prospective Randomized Trial. J Clin Oncol, 2020. 38: 3042.

[6] Morgan TM, et al. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy. J Urol. 2024;211(4):518-525.